These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
37 related articles for article (PubMed ID: 38517465)
1. Population pharmacokinetics of daptomycin in critically ill patients receiving extracorporeal membrane oxygenation. Zhang LC; Li QY; Zhang YQ; Shan TC; Li Y; Li YH; Han H; Qin WD; Guo HP; Zhao W; Tang BH; Chen XM J Antimicrob Chemother; 2024 Jul; 79(7):1697-1705. PubMed ID: 38814793 [TBL] [Abstract][Full Text] [Related]
2. Population pharmacokinetics of fluconazole in critically ill patients receiving extracorporeal membrane oxygenation and continuous renal replacement therapy: an ASAP ECMO study. Novy E; Abdul-Aziz MH; Cheng V; Burrows F; Buscher H; Corley A; Diehl A; Gilder E; Levkovich BJ; McGuinness S; Ordonez J; Parke R; Parker S; Pellegrino V; Reynolds C; Rudham S; Wallis SC; Welch SA; Fraser JF; Shekar K; Roberts JA Antimicrob Agents Chemother; 2024 Jan; 68(1):e0120123. PubMed ID: 38063399 [TBL] [Abstract][Full Text] [Related]
3. Real-world evaluation of imipenem/cilastatin/relebactam across US medical centres. Shields RK; Yücel E; Turzhitsky V; Merchant S; Min JS; Watanabe AH J Glob Antimicrob Resist; 2024 Jun; 37():190-194. PubMed ID: 38588973 [TBL] [Abstract][Full Text] [Related]
4. Relationship of imipenem therapeutic drug monitoring to clinical outcomes in critically ill patients: a retrospective cohort study. Wu Y; Lu Z; Liang P; Zhu H; Qi H; Zhang H Naunyn Schmiedebergs Arch Pharmacol; 2024 Jul; 397(7):4791-4798. PubMed ID: 38153513 [TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics of imipenem after intravenous, intramuscular and subcutaneous administration to cats. Albarellos GA; Denamiel GA; Montoya L; Quaine PC; Lupi MP; Landoni MF J Feline Med Surg; 2013 Jun; 15(6):483-7. PubMed ID: 23253883 [TBL] [Abstract][Full Text] [Related]
6. Fluconazole population pharmacokinetics and dosing for prevention and treatment of invasive Candidiasis in children supported with extracorporeal membrane oxygenation. Watt KM; Gonzalez D; Benjamin DK; Brouwer KL; Wade KC; Capparelli E; Barrett J; Cohen-Wolkowiez M Antimicrob Agents Chemother; 2015 Jul; 59(7):3935-43. PubMed ID: 25896706 [TBL] [Abstract][Full Text] [Related]
14. NONMEM population pharmacokinetics and Monte Carlo dosing simulations of imipenem in critically ill patients with life-threatening severe infections during support with or without extracorporeal membrane oxygenation in an intensive care unit. Jaruratanasirikul S; Boonpeng A; Nawakitrangsan M; Samaeng M Pharmacotherapy; 2021 Jul; 41(7):572-597. PubMed ID: 34080708 [TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics, Safety, and Tolerability of Imipenem/Cilastatin/Relebactam in Children with Confirmed or Suspected Gram-Negative Bacterial Infections: A Phase 1b, Open-Label, Single-Dose Clinical Trial. Bradley JS; Makieieva N; Tøndel C; Roilides E; Kelly MS; Patel M; Vaddady P; Maniar A; Zhang Y; Paschke A; Chen LF J Clin Pharmacol; 2023 Dec; 63(12):1387-1397. PubMed ID: 37562063 [TBL] [Abstract][Full Text] [Related]